Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:3953 |
| Name | adrenal gland cancer |
| Definition | An endocrine gland cancer located_in the adrenal glands which are located above the kidneys. |
| Source | DiseaseOntology.org |
| Alt Ids | DOID:11007 |
| Path | disease disease of cellular proliferation cancer organ system cancer endocrine gland cancer adrenal gland cancer |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|---|---|---|---|
| SMARCA4 mut TP53 mut | Dabrafenib | adrenal gland cancer | resistant | detail... |
| SMARCA4 mut TP53 mut | LY3009120 | adrenal gland cancer | resistant | detail... |
| SMARCA4 mut TP53 mut | Vemurafenib | adrenal gland cancer | resistant | detail... |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06638931 | Phase II | Nivolumab | Agnostic Therapy in Rare Solid Tumors (ANTARES) | Active, not recruiting | BRA | 0 |
| NCT07163325 | Phase I | EP102 | EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors | Recruiting | NLD | ESP | CZE | BEL | 0 |